Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: As we continue to grow our US Medical Affairs organization, we are seeking a Senior Director of Medical Affairs Content & Training to lead the development, implementation, and execution of medical and scientific content and training strategies across all US Medical Affairs teams. This role will ensure that the Medical Science Liaisons (MSLs), Medical Information, Medical Communications, Medical Strategy Leads, Medical Operations, and other Medical Affairs functions have the scientific depth, disease state knowledge, and engagement skills necessary to support external interactions with the medical and scientific community within the US Region. Reporting to the VP of US Medical Affairs, this individual will play a critical role in preparing the US team for product launches in oncology, ensuring they are equipped with the necessary knowledge and materials to communicate scientific data effectively.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior